Gemini Therapeutics (GMTX)
NASDAQ:GMTX
US Market
Holding GMTX?
Track your performance easily

Gemini Therapeutics (GMTX) Financial Statements

116 Followers

Gemini Therapeutics Financial Overview

Gemini Therapeutics's market cap is currently ―. The company's EPS TTM is $-10.046; its P/E ratio is -1.98; Gemini Therapeutics is scheduled to report earnings on March 27, 2023, and the estimated EPS forecast is $-5.90. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -3.24M$ -7.04M$ -15.16M$ -17.74M$ -18.45M
EBITDA$ -3.24M$ -7.04M$ -15.16M$ -17.69M$ -18.39M
Net Income Common Stockholders$ -3.28M$ -7.09M$ -15.23M$ -17.82M$ -18.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 101.74M$ 108.66M$ 119.06M$ 136.63M$ 150.07M
Total Assets$ 106.03M$ 113.33M$ 124.28M$ 140.44M$ 155.53M
Total Debt$ 0.00$ 2.91M$ 4.16M$ 5.40M$ 6.65M
Net Debt$ -101.74M$ -105.75M$ -114.91M$ -131.22M$ -143.42M
Total Liabilities$ 1.46M$ 6.44M$ 12.67M$ 15.60M$ 14.67M
Stockholders Equity$ 104.57M$ 106.90M$ 111.61M$ 124.84M$ 140.86M
Cash Flow-
Free Cash Flow$ -4.01M$ -9.50M$ -16.34M$ -12.68M$ -16.16M
Operating Cash Flow$ -4.01M$ -9.50M$ -16.34M$ -12.67M$ -16.10M
Investing Cash Flow---$ 405.00K-
Financing Cash Flow$ -2.91M$ -1.23M$ -1.23M$ -1.18M$ -1.25M
Currency in USD

Gemini Therapeutics Earnings and Revenue History

Gemini Therapeutics Debt to Assets

Gemini Therapeutics Cash Flow

Gemini Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis